Built for pharmacies navigating complex federal compliance standards, DSCSA 360 helps healthcare organizations manage electronic drug tracing and verification under the Drug Supply Chain Security Act.
Latrobe, Pennsylvania, April 16, 2026 – Pharmacies, wholesalers, and drug manufacturers across the United States are entering the final phase of compliance with the Drug Supply Chain Security Act, a federal law designed to strengthen the security and transparency of the nation’s pharmaceutical supply chain.
As federal enforcement milestones approach, pharmacies must implement interoperable electronic systems capable of tracing prescription drugs at the package level as they move from manufacturers to patients.
The law, enacted in 2013 as part of the Drug Quality and Security Act, established a decade-long roadmap for creating a nationwide electronic system that identifies and traces prescription drug distribution throughout the supply chain.
The system helps prevent counterfeit, stolen, or otherwise dangerous medications from entering distribution channels while improving regulators’ and manufacturers’ ability to respond quickly when suspect products appear.
According to the U.S. Food and Drug Administration, the DSCSA requires trading partners to exchange product tracing information electronically and verify the legitimacy of certain prescription drugs. These requirements form the foundation of a nationwide track-and-trace framework designed to protect patients and strengthen oversight of the pharmaceutical supply chain.
The compliance timeline now unfolds in several phases across the pharmaceutical distribution system. Federal guidance identifies the following key milestones:
- May 27, 2025: Manufacturers and authorized repackagers must comply with enhanced electronic tracing and verification requirements.
- August 27, 2025: Wholesale distributors must meet the same interoperable data exchange standards.
- November 27, 2025: Large dispensers, including pharmacies with 26 or more employees, must fully implement electronic tracing systems.
- November 27, 2026: Small dispensers with 25 or fewer full-time employees must fully implement electronic tracing systems.
The FDA stabilization period policy outlines the phased enforcement timeline intended to prevent disruptions to patient access to medications while trading partners deploy interoperable systems.
The scale of DSCSA compliance affects nearly every segment of the pharmaceutical distribution system. The National Association of Chain Drug Stores reports that more than 60,000 pharmacies operate across the United States.
Each organization that dispenses prescription drugs must now maintain the ability to exchange serialized product data, store transaction information and transaction statements, and investigate suspect or illegitimate products.
For many pharmacies, these requirements introduce significant technical and operational challenges. Systems must support data serialization, secure electronic data exchange with multiple trading partners, and retain documentation for regulatory inspections.
To help pharmacies address these challenges, PRS Pharmacy Services and Advasur developed DSCSA 360, a compliance platform that manages DSCSA requirements through a centralized workflow.
The platform enables pharmacies to receive serialized product data from trading partners, store transaction information and transaction statements required by federal regulations, verify product identifiers when investigating suspect drugs, and maintain current compliance documentation for audits and inspections.
The DSCSA 360 platform provides end-to-end visibility across the pharmaceutical supply chain, offering a complete 360-degree view of drug distribution security. This enhanced drug-tracking solution helps pharmacies, wholesalers, and manufacturers maintain compliance and streamline verification processes.
DSCSA 360 integrates seamlessly with existing pharmacy management systems, making it easier to ensure regulatory requirements are met without disrupting daily operations.
Technology platforms now play a critical role in the implementation of DSCSA. The law requires interoperable electronic systems capable of exchanging product identifiers and transaction data across manufacturers, distributors, and dispensers nationwide. These systems help identify counterfeit medications, improve traceability, and strengthen oversight of the pharmaceutical supply chain.
Pharmacies and healthcare organizations preparing for DSCSA compliance milestones can explore the DSCSA 360 platform and learn how it supports federal electronic track-and-trace requirements, as supported by DrugSupplyTrack, PRS’s Drug Supply Chain Policy and Procedures Compliance Program.
Early preparation allows pharmacies to maintain uninterrupted medication distribution while ensuring compliance with federal drug safety regulations.
About PRS Pharmacy Services
PRS Pharmacy Services, founded in 1982, is a duly recognized pharmacy consulting firm endorsed by the National Community Pharmacists Association (NCPA). The company focuses on a full suite of services for independent pharmacy owners and professionals, including compliance programs, operational evaluations, pharmacy brokerage, staff training and staffing solutions, and turnkey ownership programs. Thousands of pharmacies across the United States rely on PRS for regulatory support and business consulting.
Contact:
PRS Pharmacy Services
Website: prsrx.com
Compliance Solutions: prsrx.com/compliance/dscsa360
Phone: (800) 338-3688
Email: [email protected]
